ENTITY
CStone Pharmaceuticals

CStone Pharmaceuticals (2616 HK)

90
Analysis
Health CareHong Kong
CStone Pharmaceuticals operates as a biotechnology company. The Company develops immuno-oncology and molecularly targeted drugs to address unmet medical needs for cancer patients. CStone Pharmaceuticals serves customers worldwide.
more
Company Event19 Aug 2020 10:00 • Latest
No more events
x